E Kumar Sharma
With COVID-19 cases rising, what can those with comorbidities do to stay safe?
Diabetes is a chronic ailment and has to be managed lifelong and if properly monitored then apparently there is nothing to worry about, but then connect with the doctor and regular checkups are critical.
Vaccine registration opens for all adults at 4 PM on Co-Win app: What to expect from May 1?
The vaccines are all also still under emergency use authorization and therefore clarity on their supplies is crucial.
Molnupiravir approval sought to target early stage COVID-19 cases: Natco vice chairman
Natco Pharma’s involvement with Molnupiravir and its relation with the US pharma giant Merck (MSD), which is behind the development of this drug, is however not clear and also not spelt out in the note to the bourses.
Can cryptocurrency bulls provide relief to India’s COVID-19 crisis?
In a sense, as one expert who has looked at this subject closely but does not wish to be identified, says, “it is viewed as any venture capital (VC) or private equity (OE) supporting Covid cause but in this case, stands out
COVID-19: Can India salvage the situation? Here’s what it is doing
At a time when those who are involved with mathematical modelling of the COVID situation and giving projections of the likely peak that India can expect in May, there is a view that a lot could be done to save the situation.
Why is Covaxin’s final safety and efficacy report coming only in June? Bharat Biotech clarifies
The Phase 3 study enrolled 25,800 participants between 18 and 98 years of age, including 10 percent over the age of 60, with analysis conducted 14 days post 2nd dose.
World Innovation Day: How a healthcare crisis is fostering new ideas and forcing research-culture change
From new vaccines that were made in a matter of months to new technology platforms to the sheer creativity, India has become hub of path-breaking innovation.
M Narasimham, who set the intellectual framework for banking reforms in India, passes away
Born on June 3, 1927 and residing in Hyderabad, Narasimham was soon to turn 94.
India’s COVID-19 battle: Why is there an outcry for Remdesivir and concerns over the effectiveness of vaccines on the virus
If the goal is to check the transmission then 45 years and above is not the target population because transmission is more through younger people.
Where did the govt’s Rs 900 crore R&D grant for COVID vaccine development go?
Today, almost all the possible technology platforms deployed globally are also being worked upon in India and it is not as if factories are to be found to make them. There are at least half a dozen leading Indian vaccine make
Sputnik V approved: But can it resolve the COVID19 vaccine supply shortage in India?
Experts don't see a quick change in vaccine supply scene, but the approval is a good sign for Dr Reddy's labs.
How the global vaccine hub – India is left scrambling for ways to ramp up vaccine capacities
Most experts have maintained that getting as many people inoculated as possible is the only defense available under the current circumstances and if 70 per cent of India is to be inoculated there is no denying that the demand
Face-masks, social distancing & ramped up vaccinations at 10 million doses a day crucial now: Dr Gagandeep Kang
What has complicated matters apparently is that this has happened at a time when the new variants have entered India and local variants are emerging leading to a further spiralling of the viral caseload.
There is more to DMart Founder Damani than his newly acquired Rs 1,000 crore home in Mumbai
Kishore Biyani, the trail blazer in Indian retail who has experimented with a range of formats and exited, sees Damani as “a simple, humble person who works with limited number of variables and is highly focussed.”
New ISB dean designate Madan Pillutla on B-schools in the new pandemic reality
Currently, an incredibly busy professor of organizational behaviour, a department that he chaired in the past at the London Business School, managed to take time out to speak exclusively to Financial Express online.
What to look out for in the Supreme Court judgement in the Tata-Mistry case
Corporate India would be keen to read the Supreme Court judgement today and absorb the flavour and thinking of the court for future matters.
Double mutation concerns: COVID-19 vaccines working but studies on to assess potential resistance
Speaking to Financial Express Online, he says, these mutations need to be watched closely and studied because they are in the region of the spike protein of the virus, which is also the location that is targeted by most of th
World TB day: A grim reminder on urgent steps to reverse the setback for India’s major killer disease care
TB has always been an area of concern for India, not just for the sheer numbers involved but also because of the nature of disease, which is contagious and left untreated can lead to serious illness and death.
Janata Curfew Anniversary: Experts say get back to basics with COVID testing, tracing, isolation & vaccines for the young
The India numbers become important at a time when there is a rising COVID-19 caseload in the country.
Sebi’s ‘Accredited Investors’ note reaction: Networth not a surrogate for financial acumen
The intention is laudable though the timing may be debatable. Market regulator, Securities Exchange Board of India (Sebi), will today, Thursday, March 18 th , close the window on receiving the views on its consultation paper
India’s National Vaccination Day: Prickly questions that still confront the vaccine hub of the world
Today, 16 March, is National Vaccination day, which some have traditionally also referred to as the national immunisation day.
Quad Summit: Fillip to Biological E with a huge endorsement for India on the global vaccine map
Now, the Quad summit adds a new dimension. It will help support the creation of capacity at Biological E to make and supply 1 billion doses by 2022 in the Indo-Pacific region.
How 3 hours & 10 experts finally got indigenous Covaxin its safety and efficacy tag
The company had claimed an interim clinical efficacy of 81 percent in its announcement on March 3rd and had got favourable reactions from experts.
Pandemic made women redefine entrepreneurship: SEWA Bank MD Jayshree Vyas
The pandemic-ravaged months have taken a heavy toll on everyone and especially on women, who sadly were the first set of people in many households to take a hit on their careers - either due to a job loss or by opting out to
Interview: Muhammad Yunus on micro-credit & social impact models for a changed world
Microcredit programmes must learn to survive under all disaster situations. Giving up is not an option. One has to be innovative. Complaining about one thing or other for failure will not get microcredit anywhere, he said.
Solar-powered COVID-19 vaccines storage market sees new player with hybrid offering
Companies in India have not been new to solar-powered solutions in healthcare with some deploying off-grid solutions for a long time now.
Covaxin interim efficacy very good, awaiting more data and full results: Dr Gagandeep Kang
“Interim efficacy results are a planned analysis and are showing very good results for Covaxin. This is excellent news,” says Dr Gagandeep Kang, a highly regarded medical scientist and professor at the Christian Medical C
Advertisement
US Stock Market
View All- Elon Musk, Jeff Bezos, Warren Buffett, others lose over $26 billion wealth due to Evergrande crisis
- Dow futures tank 500 pts ahead of Fed meet as US stock indices, FAANGM turn negative month-to-date
- Investment opportunities at all-time high stock market levels and how to navigate volatility
- Wall Street tech stocks running out of steam; value stocks could take centre stage now
- US Stocks get ‘monster’ inflows as traders exit cash on Fed relief
Most Read
- Zee Entertainment to merge with Sony Pictures; Punit Goenka to remain MD, fends off ouster attempts
- Sensex, Nifty stare at cautious start on Wednesday; key things to know before market opens
- Share Market LIVE: SGX Nifty sits in red ahead of opening; Paras Defence IPO oversubscribed on day 1 of sale
- It's all about Jio: How sports is a key part of Reliance Industries gameplay in India
- Zee Entertainment, SBI Cards, Reliance Industries, Torrent Power, Infosys, Nucleus stocks in focus
- Demand Seen: Loan guarantee scheme to stay through FY22
- Repeal of coal mine leases again; now Adani Power loses Jitpur block
- Reliance set to take over JBF Industries with CFM ARC
- ZEEL institutional investors likely to support call to remove directors
- Agri exports jump 22% to $7.9 bn in April-August
Advertisement
Top News
- Zee Entertainment to merge with Sony Pictures; Punit Goenka to remain MD, fends off ouster attempts
- Sensex, Nifty stare at cautious start on Wednesday; key things to know before market opens
- Share Market LIVE: SGX Nifty sits in red ahead of opening; Paras Defence IPO oversubscribed on day 1 of sale
- It's all about Jio: How sports is a key part of Reliance Industries gameplay in India
- Zee Entertainment, SBI Cards, Reliance Industries, Torrent Power, Infosys, Nucleus stocks in focus
- Demand Seen: Loan guarantee scheme to stay through FY22
- Repeal of coal mine leases again; now Adani Power loses Jitpur block
- Reliance set to take over JBF Industries with CFM ARC
- ZEEL institutional investors likely to support call to remove directors
- Agri exports jump 22% to $7.9 bn in April-August
Advertisement
